ANTIHYPERCHOLESTEROLEMIA ACTIVITY STUDY OF SIMVASTATIN WITH LIPID NANOPARTICLES (LNP) AS DRUG DELIVERY SYSTEM IN HEPG2 CELLS
High levels of Low Density Lipoprotein (LDL) cholesterol in plasma will cause thickening and sticking of LDL cholesterol to the plasma wall and cause plaque which can lead to atherosclerosis. Hypercholesterolemia is the biggest risk factor for atherosclerosis where there is an increase in chol...
Saved in:
Main Author: | Rula Akifah, Latisha |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/78419 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
ANTIHYPERCHOLESTEROLEMIA ACTIVITY STUDY OF SIMVASTATIN WITH LIPID NANOPARTICLES (LNP) AS DRUG DELIVERY SYSTEM IN HEPG2 CELLS
by: Rula Akifah, Latisha -
FORMULATION, CHARACTERIZATION, AND IN VITRO TOXICITY TEST OF LIPID NANOPARTICLE DOSAGE FORM FOR SIMVASTATIN DRUG DELIVERY
by: Ricardo Setiadi, Anfield -
Lipid-coated polymeric nanoparticles for cancer drug delivery
by: Krishnamurthy, Sangeetha, et al.
Published: (2015) -
Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: A possible role in statin-induced hepatotoxicity?
by: Tavintharan, S., et al.
Published: (2011) -
Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: A possible role in statin-induced hepatotoxicity?
by: Tavintharan, S., et al.
Published: (2011)